Table 1.

Patient and tumor characteristics

	Per patients (1st lesion)	Per lesion/treatment
Gender
Female	49 (47.1%)	61 (46.2%)
Male	55 (52.9%)	71 (53.8%)
Age (at SBRT, years)
Median (range)	66.4 (28.2–87.6)	65.2 (28.2–86.6)
Location of the lesion
Periferal		80 (61%)
Central		52 (39%)
Primary sites
Lung	49 (47.1%)
Gastro-intestinal	35 (33.7%)
Other	20 (19.2%)
Primary histology
Adenocarcinoma	67 (64.4%)	86 (65.2%)
Other	37 (35.6%)	46 (34.8%)
Lesion treated at same time (on same CT)
1	82 (78.8%)
2	16 (15.4%)
3	4 (3.8%)
4	2 (1.9%)
Prior chemotherapy for primary tumor
Yes	25 (24%)	27 (20.5%)
No	79 (76%)	105 (79.5%)
Performance status
0	24 (23.1%)	29 (22%)
1	71 (68.3%)	91 (68.9%)
2	9 (8.7%)	12 (9.1%)
Previous treatments (per patient)a
Surgery	45 (34.1%)
Chemotherapy	47 (35.6%)
Radiotherapy	42 (31.8%)
Other	57 (43.2%)

^acombined treatments are counted separately